Join

Compare · DCGO vs OPCH

DCGO vs OPCH

Side-by-side comparison of DocGo Inc. (DCGO) and Option Care Health Inc. (OPCH): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both DCGO and OPCH operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
  • OPCH is the larger of the two at $3.15B, about 58.6x DCGO ($53.8M).
  • Over the past year, DCGO is down 66.1% and OPCH is down 36.6% - OPCH leads by 29.5 points.
  • OPCH has been more active in the news (13 items in the past 4 weeks vs 2 for DCGO).
  • OPCH has more recent analyst coverage (15 ratings vs 10 for DCGO).
PerformanceDCGO-66.09%OPCH-36.63%
2025-06-09+0.00%2026-06-08
MetricDCGOOPCH
Company
DocGo Inc.
Option Care Health Inc.
Price
$0.54-2.72%
$20.07-2.00%
Market cap
$53.8M
$3.15B
1M return
-13.45%
-3.28%
1Y return
-66.09%
-36.63%
Industry
Medical/Nursing Services
Medical/Nursing Services
Exchange
NASDAQ
NASDAQ
IPO
2020
News (4w)
2
13
Recent ratings
10
15
DCGO

DocGo Inc.

DocGo, Inc. provides mobile health services and integrated medical mobility solutions in 26 states in the United States and the United Kingdom. The company's AI-powered transportation and concierge medical services enable its clinical professionals to facilitate patient-centered care, helping improve patient outcomes while reducing the total cost of care for its customers. It also provides medical transport services. As of October 1, 2021, the company had 3,500 medical providers. It serves facilities, hospital networks, and health insurance providers. The company was founded in 2015 and is headquartered in New York, New York.

OPCH

Option Care Health Inc.

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies. It also offers infusion therapies for bleeding disorders; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications. In addition, the company offers therapies that women need to survive and thrive through high-risk pregnancies; treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; and nursing services. The company is headquartered in Bannockburn, Illinois.

Latest DCGO

Latest OPCH